approved EB-1A
Postdoctoral Research Associate
Diabetes Mellitus · India · 2025-04-25
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.
Framework Evaluation
3 of 3 criteria metScholarly Articles (Met)
The petitioner authored 12 peer-reviewed publications in prestigious journals such as Hepatology and The FASEB Journal.
Judging (Met)
The petitioner served as a reviewer for at least 14 journals and held positions on multiple international editorial boards.
Original Contributions (Met)
His research on diabetes treatments and Zika virus virulence has been cited over 468 times, influencing scholars globally.
Why This Petition Was Approved
The petition was approved based on 12 peer-reviewed publications with over 468 citations, including a paper in the top 10% of its field. The petitioner demonstrated extraordinary ability through his service as a reviewer for 14 journals and his role on multiple international editorial boards. His research into type 2 diabetes treatments and Zika virus virulence provided evidence of original contributions of major significance.
Evidence
Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Judging Experience
Original Contributions
Evidence Submitted
- 12 peer-reviewed publications in high-impact journals like Hepatology (IF 13), Vaccines, and The FASEB Journal
- Over 468 citations from scholars in more than 50 countries
- One paper ranked in the top 10% most-cited articles in Molecular Biology & Genetics
- Reviewer for at least 14 peer-reviewed journals including Scientific Reports and Frontiers in Neuroscience
- Editorial board memberships for multiple international scientific journals
- Original scientific contributions regarding carvacrol and rosiglitazone for type 2 diabetes
- Identification of glycosylation motifs on the Zika virus
- Research on placental cell dysfunction and Acute Fatty Liver of Pregnancy (AFLP)
Similar Cases
Research Assistant
Pharmaceuticals · India
WeGreened EB-1A approved
145 days 2023-01-24
The case was approved based on the petitioner's 15 peer-reviewed scientific articles with a cumulative impact factor of 69.504 and 233 citations from peers in 37 countries. He demonstrated extraordinary ability through 92 peer review assignments and editorial positions at 5 prestigious journals. His research provided practical applications for treating complex diseases like diabetes and tuberculosis.
Assistant Professor
Healthcare · Pakistan
WeGreened EB-1A rfe approved
Oklahoma 98 days 2025-07-05
The petition was approved based on meeting three EB-1A criteria: judging the work of others, scholarly authorship, and original contributions of major significance. Metrics included 30+ peer reviews, an associate editor role, 5 journal articles, 5 scientific abstracts, and 144 citations from researchers in over 30 countries.
Researcher
Biotechnology · India
WeGreened EB-1A approved
California 40 days 2022-03-21
The approval was based on 17 peer-reviewed articles and 1 preprint which garnered 607 citations from peers in 49 countries. The petitioner also demonstrated authority through 6 peer-review assignments and was ranked in the top 1% of highly cited authors in Chemistry over the past 10 years. These metrics satisfied the EB-1A criteria for scholarly articles, original contributions, and judging.
Cardiologist
Healthcare · Pakistan
WeGreened EB-1A approved
Ohio 82 days 2025-03-12
The petition was approved based on 21 peer-reviewed journal publications and 21 scientific abstracts with over 120 citations. Evidence showed multiple articles ranked among the top 10% and 1% most cited in Clinical Medicine for their year of publication. The petitioner also demonstrated expert status through 13 confirmed peer reviews for high-impact medical journals.
Frequently Asked Questions
A approved EB-1A (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.
Browse More Cases
Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-04-25.
Browse all casesAt a Glance
Outcome approved
Processing 16 days
Criteria Met 3 / 3
Evidence Types 5
EB-1A Case Data
Scraped Case Data
Total Cases 881
Success Rate 52.9%
Sustained 466
Dismissed 299
Related Pages
Get Case Insights
Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.
Join Waitlist